Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -579.88% is 97% below its 5-year average of -294.15%, around the middle of its 5-year range (-1087.23%–0.00%).
85.45% below its 12-month average of -312.68%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -213.73%.
EBITDA MARGIN
-579.88%
EBITDA MARGIN AVG TTM
-312.68%
EBITDA MARGIN AVG 3Y
-302.65%
EBITDA MARGIN AVG 5Y
-294.15%
EBITDA MARGIN AVG 10Y
-447.12%
EBITDA MARGIN AVG 15Y
-361.08%
EBITDA MARGIN AVG 20Y
-345.69%
CURRENT VS TTM AVG
-85.45%
CURRENT VS 3Y AVG
-91.60%
CURRENT VS 5Y AVG
-97.14%
CURRENT VS 10Y AVG
-29.69%
CURRENT VS 15Y AVG
-60.60%
CURRENT VS 20Y AVG
-67.74%
Dyadic International, Inc.
Market Cap
$16.58M
EBITDA Margin
-579.88%
TTM Avg
-312.68%
3Y Avg
-302.65%
5Y Avg
-294.15%
Market Cap
$16.64M
EBITDA Margin
-82.81%
TTM Avg
-187.23%
3Y Avg
-342.47%
5Y Avg
-369.32%
Market Cap
$17.15M
EBITDA Margin
-521.61%
TTM Avg
-265.78%
3Y Avg
-984.51%
5Y Avg
-733.51%
Market Cap
$17.51M
EBITDA Margin
-168.69%
TTM Avg
-262.41%
3Y Avg
-983.34%
5Y Avg
-3401.51%
Market Cap
$15.78M
EBITDA Margin
-13679.31%
TTM Avg
-8051.39%
3Y Avg
-4553.85%
5Y Avg
-5076.49%
Market Cap
$15.75M
EBITDA Margin
-14633.33%
TTM Avg
-7486.14%
3Y Avg
-4543.27%
5Y Avg
-3157.51%
Market Cap
$15.37M
EBITDA Margin
-468.17%
TTM Avg
-602.06%
3Y Avg
-602.06%
5Y Avg
-23374.02%
Market Cap
$15.04M
EBITDA Margin
-29916.57%
TTM Avg
-29916.57%
3Y Avg
-29916.57%
5Y Avg
-29916.57%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyadic International, Inc. (DYAI) | $16.58M | -579.88% | -312.68% | -302.65% | -294.15% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -82.81% | -187.23% | -342.47% | -369.32% |
| Lipocine Inc. (LPCN)vs › | $17.15M | -521.61% | -265.78% | -984.51% | -733.51% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.51M | -168.69% | -262.41% | -983.34% | -3401.51% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | -13679.31% | -8051.39% | -4553.85% | -5076.49% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | -14633.33% | -7486.14% | -4543.27% | -3157.51% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.37M | -468.17% | -602.06% | -602.06% | -23374.02% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.04M | -29916.57% | -29916.57% | -29916.57% | -29916.57% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.96M | N/A | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.92M | -779.07% | -389.93% | -389.93% | -2320.55% |
Gross Margin
-88.3%
EBITDA Margin
-579.9%
Operating Margin
-579.9%
Net Margin
-219.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -213.73% |
| 2026-03-31 | -172.13% |
| 2025-12-31 | -639.15% |
| 2025-09-30 | -165.32% |
| 2025-06-30 | -373.09% |
| 2025-03-31 | -1087.23% |
| 2024-12-31 | -186.63% |
| 2024-09-30 | -10.35% |
| 2024-06-30 | -529.31% |
| 2024-03-31 | -635.22% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | -433.21% |
| 2023-06-30 | -273.60% |
| 2023-03-31 | -209.65% |
| 2022-12-31 | -3.54% |
| 2022-09-30 | -211.86% |
| 2022-06-30 | -503.83% |
| 2022-03-31 | -423.28% |
| 2021-12-31 | -6.64% |
| 2021-09-30 | -479.70% |
| 2021-06-30 | -412.67% |
| 2021-03-31 | -721.06% |
| 2020-12-31 | -655.89% |
| 2020-09-30 | -618.77% |
| 2020-06-30 | -533.70% |
| 2020-03-31 | -755.46% |
| 2019-12-31 | -0.70% |
| 2019-09-30 | -3.02% |
| 2019-06-30 | -1.26% |
| 2019-03-31 | -1.50% |
| 2018-12-31 | -251.52% |
| 2018-09-30 | -668.00% |
| 2018-06-30 | -1126.09% |
| 2018-03-31 | -1204.40% |
| 2017-12-31 | -972.72% |
| 2017-09-30 | -509.45% |
| 2017-06-30 | -712.55% |
| 2017-03-31 | -1368.56% |
| 2016-12-31 | -363.03% |
| 2016-06-30 | -8752.08% |
| 2016-03-31 | -1153.59% |
| 2015-12-31 | -2072.92% |
| 2015-09-30 | -385.11% |
| 2015-06-30 | -5206.61% |
| 2015-03-31 | -2145.94% |
| 2014-12-31 | -6.05% |
| 2014-09-30 | 19.42% |
| 2014-06-30 | -46.31% |
| 2014-03-31 | -45.26% |
| 2013-12-31 | -8.55% |
| 2013-09-30 | -34.56% |
| 2013-06-30 | 50.69% |
| 2013-03-31 | -49.64% |
| 2012-12-31 | -46.34% |
| 2012-09-30 | -26.98% |
| 2012-06-30 | 54.49% |
| 2012-03-31 | -21.55% |
| 2006-12-31 | -96.15% |
| 2006-09-30 | -55.05% |
| 2006-06-30 | -70.45% |
| 2006-03-31 | -55.41% |
| 2005-12-31 | -58.09% |
| 2005-09-30 | -54.82% |
| 2005-06-30 | -52.26% |
| 2005-03-31 | -72.13% |
| 2004-12-31 | -29.91% |
| 2004-06-30 | -64.94% |
| 2004-03-31 | -51.35% |
| 2003-12-31 | -18.77% |
| 2003-06-30 | -121.14% |
| 2003-03-31 | -155.39% |
